🇺🇸 n-acetylcystine in United States

12 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Cough — 2 reports (16.67%)
  2. Hypotension — 2 reports (16.67%)
  3. Acute Hepatic Failure — 1 report (8.33%)
  4. Akathisia — 1 report (8.33%)
  5. Alanine Aminotransferase Increased — 1 report (8.33%)
  6. Anxiety — 1 report (8.33%)
  7. Apgar Score Low — 1 report (8.33%)
  8. Aspartate Aminotransferase Increased — 1 report (8.33%)
  9. Atrial Fibrillation — 1 report (8.33%)
  10. Atrial Flutter — 1 report (8.33%)

Source database →

n-acetylcystine in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is n-acetylcystine approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for n-acetylcystine in United States?

Assiut University is the originator. The local marketing authorisation holder may differ — check the official source linked above.